Reference Pricing and Consumer-Directed Health Care
Public and Private Payer Responses to Pharmaceutical Prices in the United States, BNP Paribas, Atelier (roundtable for pharmaceutical executives). University of Glasgow, Institute of Health and Wellbeing. Glasgow, UK. 09.27.16.
Reference Pricing in Health Insurance, University of Utah, Department of Economics. Salt Lake City, UT. 08.29.16.
Pricing and Patient Access: Strategies and Negotiations between Payers and Pharmaceutical Firms in the US, Roche Group, Italy. Milan, Italy. 06.30.16.
Cost-based, Value-based, and Reference-based Pricing for Diagnostics, International Society for Pharmacoeconomics and Outcomes Research (ISPOR), annual European conference, workshop on economics of diagnostics, Milan, Italy November 8, 2015.
Reference Pricing as an Employer and Insurer Strategy for Cost Control. James Robinson. National Institute for Health Care Management; Webinar onPayment Reform: State and Private Sector Innovations; August 16, 2012.
Kaiser Permanente: Southern California Permanente Leadership Conference. James Robinson. City of Industry, California, July 16, 2012.
Impact of Increasing Consumer Cost Sharing on Physician Organizations: The Good, the Bad, and the Inevitable. James Robinson. University of Pittsburgh Medical Center, UPMC Health Plan, annual conference, Pittsburgh, PA October 28, 2014
Value Purchasing in Orthopedics: Price Transparency, Bundled Payment, and Reference Pricing. American Association of Orthopedic Surgery (AAOS), conference on value health care. Washington DC, May 2014.
Consumer Cost Sharing: The Ranges of Alternatives. James Robinson.Aligning Payment Reform and Benefit Design. Kim MacPherson. Additional presentations by Aldo de la Torre and Brad Wolfsen. Pay for Performance Summit: Mini-Summit III: Insurance Benefit Design and Cost Sharing for Payment Reforms; March 20, 2012.
Consumer Cost Sharing and Use of High-Cost Biopharmeucticals. James Robinson. California Public Employees Retirement System (PERS); Pension and Health Benefits Committee. Sacramento, California. March 13, 2012.
Orphan Diseases Or Population Health? Policy Choices Drive Venture Capital Investments. Dayton Misfeldt and James C. Robinson, Health Affairs Blog, July 21, 2017
“MedTech Innovation Amid Changing Dynamics for Physicians, Hospitals, and Consumers.” University of Texas, Dell School of Medicine, Austin TX. 06.23.16.
Life Sciences Innovation Amid Changing Market Dynamics. Luncheon investor meeting, Barclays Equity Analysis, New York, March 24, 2016.
“Promoting Innovation and Affordability in Health Care.” East Bay Leadership Council, annual conference on health care. San Ramon, CA September 25, 2015
“Mobile Technology as a Platform to Support Price Transparency.” University of Paris-Descartes, Faculty of Pharmacy, colloquium on digital health. Paris, France, May 28, 2015
Purchasing Medical Innovation: Price Transparency, Bundled Pricing, and Reference Pricing. James Robinson. AMD3 Foundation annual Value in HealthCare Conference, Duquesne Club, Pittsburgh, PA February 13, 2015
Biomedical Innovation in the Era of Health Care Spending Constraints, James Robinson. Health Affairs, Press Briefing, Washington DC, February 5, 2015
Public and Private Health Insurance Pricing for Innovative and Expensive Drugs in the U.S. James Robinson. University of Paris, Department of Pharmacy and Biologics, Colloquium on Value-based Pricing, Paris December 10, 2014.
MedTech Innovation Amid Changing Dynamics for Insurers, Hospitals, and Consumers. Keynote address to Deutsche Bank MedTech Bootcamp, Boston, March 21, 2013.
Innovation and Affordability in Biomedical Technology. James Robinson.UC Berkeley Homecoming 2012; April 21, 2012.
Hospital Consolidation: the good, the bad, and the backlash. Keynote address to Manhattan Institute conference on hospital market power, Harvard Club, New York City, March 23, 2016.
“Physician-Hospital Consolidation: The Good, the Bad, the Solution.” Healthcare Association of Southern California, Annual Conference. Carlsbad, CA, April 23, 2015.
Health Plan Strategies for Controlling Health Care Costs. James Robinson. California Health Benefits Exchange; Board of Directors Meeting and Public Forum; February 21, 2012.
Health Financing Reform in the United States: Overview and Implications for the Pharmaceutical Industry. 5th Seminar of Economic Themes of Health; Paris, France; May 27, 2010.
Accountable Care Organizations in California: Lessons for the National Debate on Delivery System Reform. Integrated Healthcare Assocation; October 25, 2010.
“Biomedical Innovation in an Era of Health Care Cost Restraint.” Health Affairs. Press Briefing, Biomedical Innovation. Washington DC, February 5, 2015.
Evolution of Insurer Strategies for Managing Biopharmaceuticals in the U.S. James Robinson. Current State and Future Outlook for Pharmaceutical Risk Sharing Agreements. Kim MacPherson. University of Paris Descartes. Seventh Annual University Descartes-Evry-Berkeley Colloquium; May 24, 2012.
John Muir Hospital and Warner Pacific Health Services; Health Care Reform Summit. James Robinson. Walnut Creek, California; April 24, 2012.
Managing Biopharmaceuticals in the Private Health Sector. Centers for Medicare and Medicaid Services, Region IX; June 23, 2009.
Managing Biopharmaceuticals in the U.S. — Public Policy and Market Strategy. University of Paris, Faculty of Pharmacy; Paris, France; May 13, 2009.
Health Financing Reform in the United States: Overview and Implications for the Pharmaceutical Industry. James Robinson. 5th Seminar of Economic Themes of Health; Paris, France; May 27, 2010.
December 2014: University of Paris
JC Robinson. Public and Private Health Insurance Pricing for Innovative and Expensive Drugs in the U.S.
December 2014: Roche, Basel Switzerland.
JC Robinson. Challenges and Opportunities Facing the US Biopharmaceutical Industry.
Value Based Health Care and Pay-for-Performance
U.S. Experience with Physician Payment Reform: Implications for U.K. Commissioning. Keynote address by James Robinson to King's Fund Conference, Payment Reform: Moving beyond Payment by Results (link is external). Dr. Robinson's slides are available, as are video highlights of histalk(link is external).
"Innovation in Physician Payment and Organization for Cancer Care" presentations and audio from the BCHT webinar held on November 28, 2012, which focused on an innovative pilot between Wellpoint and Wilshire Oncology on an oncology medical home.
- Presentation by James C. Robinson, PhD, Leonard D. Schaeffer Professor of Health Economics, University of California at Berkeley; Director, Berkeley Center for Health Technology
- Presentation by Linda D. Bosserman, MD, FACP, Medical Oncologist and President, Wilshire Oncology Medical Group, an Affiliate of US Oncology
- Presentation by Jennifer Malin, MD, PhD, Medical Director Oncology, WellPoint, Inc., Thousand Oaks
- Presentation by Kimberly MacPherson, MBA, MPH, Program Director, Health Policy and Management, University of California at Berkeley; Co-Director, Berkeley Center for Health Technology
- Webinar Recording [~10MB .mp3 file]
- Health Care Cost Trends and Employers’ Cost Control Strategies. James Robinson. Kern Economic Development Corporation; Annual Economic Summit; March 21, 2012.
Price Transparency and Value-Based Purchasing in Health Services.National Business Coalition on Health: Annual Conference; February 16, 2012.
American Academy of Orthopedic Surgery Annual Conference; Session on Measuring Quality and Value in Orthopedic Surgery. James San Francisco. February 10, 2012.
Purchaser Initiatives to Improve Value for Spine Surgery. Integrated Healthcare Assocation; October 25, 2010.
Explaining Hospital Prices and Profits : Medicare Cost Shifting or Market Concentration? Academy Health Annual Research Meeting; June 29, 2010.
Comparative Effectiveness Research: Clinical Evidence and Economic Incentives. 5th Seminar of Economic Themes of Health; Paris, France; May 27, 2010.
Improving Value for Medical Devices. Hospital Association of Southern California; April 17, 2009.
Value Purchasing in Orthopaedics. American Academy of Orthopaedic Surgeons; February 25, 2009.
Value-Based Health Care: The Role of Pharmaceuticals. Foundation for Managed Care Pharmacy; February 4, 2009.
Pursuing Value for Medical Devices in Orthopaedics. University of California, San Francisco Department of Orthopaedics; October 22, 2008.
Value-Based Purchasing of Drugs, Biologics, and Medical Devices. America's Health Insurance Plans; June 19, 2008.
Pursuing Value for Medical Devices: Hospitals and Manufacturers. Integrated Healthcare Association / California Hospital Association Conference; May 21, 2008.